DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

69.08 -0.77 (-1.10%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $69.08 -1.10%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.38
Previous Close $69.85
Daily Range $68.32 - $69.77
52-Week Range $55.04 - $84.25
Market Cap $10.2B
P/E Ratio -52.92
Dividend (Yield) $0.00 (0.0%)
Volume 1,677,177
Average Daily Volume 1,019,439
Current FY EPS -$1.30

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary

3 Best Stocks for Investing in Biotech

Gilead Sciences, Celgene Corp, and BioMarin are three biotech industry companies that are revolutionizing how doctors treat patients.

January 2017 Options Now Available For BioMarin Pharmaceutical (BMRN)

Jim Cramer's Top Stock Picks: GPRO SKX DECK ATK RTN LMT BMRN

Merck KGaA's Kuvan Effective in Under-4 Year Olds - Analyst Blog

Notable Two Hundred Day Moving Average Cross - BMRN

Roof Leaker To Watch: Biomarin Pharmaceutical (BMRN)

Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analys

Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower

Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the T

Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

See More BMRN News...

BMRN's Top Competitors

BMRN $69.08 (-1.10%)
Current stock: BMRN
AMGN $142.18 (-1.27%)
Current stock: AMGN
GILD $105.47 (-0.46%)
Current stock: GILD
BIIB $329.76 (0.16%)
Current stock: BIIB